Marpai (MRAI) director awarded 125,000 shares; now holds 989,073
Marpai, Inc. (MRAI) — Director equity award Director Yaron Eitan acquired 125,000 shares of Class A Common Stock on 10/20/2025 at a reported price of $0, reflecting settlement of RSUs that were deemed fully vested on the issuance date.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Marpai, Inc. (MRAI) — Director equity award
Director Yaron Eitan acquired 125,000 shares of Class A Common Stock on 10/20/2025 at a reported price of $0, reflecting settlement of RSUs that were deemed fully vested on the issuance date. Following the transaction, he beneficially owned 989,073 shares, held directly.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Class A Common Stock | 125,000 | $0.00 | $0.00 |
Footnotes (1)
- F1. The RSUs are deemed fully vested on the issuance date.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Marpai (MRAI) disclose in this Form 4?
What is the reporting person’s relationship to Marpai (MRAI)?
Was this filing submitted by one or multiple reporting persons?
What type of security was involved in the transaction?
What was the transaction code used in the filing?
AI-generated analysis. How Rhea-AI works. Not financial advice.